Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications    » Alzheimer's    » Amputations    » Blindness    » Bone Loss    » Broken Bones    » Cancer    » Cardiovascular    » Cholesterol    » Cognitive Function    » Complications    » Death    » Dementia    » Dental    » Depression    » Eyes    » Feet    » Foot Ulcers    » Hearing Loss    » Heart Disease    » Hypertension    » Hypoglycemia    » Kidney Disease    » Lung    » Memory    » Neuropathy    » PAD    » Pain    » PCOS    » Pneumonia    » Retinopathy    » Stress    » Stroke    » Wounds Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Complications » Cardiovascular

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Prevalence of Diabetes Rose 5% Annually Since 1990 Posted: Saturday, June 30, 2007

CDC statistics highlight need for improved prevention efforts.

Diabetes Reduces Life Expectancy by 8 Years Posted: Friday, June 22, 2007

Before heart disease even develops among patients with heart disease, the effects on life expectancy have already begun, found researchers.

New Study Shows No Increased Heart Risk With Avandia Posted: Thursday, June 14, 2007

Findings from an interim analysis of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), shows further proof the safety of Avandia.

FDA Orders New Safety Labels for Rosiglitazone (Avandia) and Pioglitazone (Actos) Posted: Thursday, June 14, 2007

The FDA Commissioner Andrew C. von Eschenbach, M.D., told a congressional hearing that the FDA will beef up the cardiovascular warnings on the labels of both rosiglitazone (Avandia) and pioglitazone (Actos).

Diabetic Cardiomyopathy Can Occur Soon After Diabetes Appears Posted: Friday, June 08, 2007

Dramatic losses of a key biochemical substance in heart muscle tissue occur in the very earliest stages of diabetes, according to a new study.

Prescriber's Letter Clarifies Avandia Heart Attack Warning With Algorithm Posted: Friday, June 08, 2007

Analysts at Prescriber's Letter say that crunching the study's numbers reveals only part of the story. Since this report is a meta-analysis, it is merely a study of prior study results.

Postprandial Glucose Levels Tied To CVD Risk in Type 2 Diabetes Posted: Friday, June 01, 2007

Postprandial glucose levels play an important and often overlooked role in cardiovascular disease in type 2 diabetes patients.

Avandia Tied To 43% Increased Heart Attack Risk In Study Posted: Friday, May 25, 2007

Analysis reveals Avandia linked to 43 percent increased risk for heart attack and 64 percent greater risk of cardiovascular death.

Coronary Calcification Independently Predicts All-Cause Mortality Posted: Thursday, May 17, 2007

The results of a new study show that, the coronary artery calcification (CAC) score, measured by electron beam tomography, provides incremental information independent of traditional risk factors on all-cause mortality risk.

Aspirin Underused in US Adults Posted: Thursday, May 03, 2007

One of the factors most strongly associated with aspirin use was a discussion with a healthcare provider about its use--88% of the 41% of people who said they took aspirin regularly also said they had discussed aspirin use with their doctors.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.